Display options
Cite
Zivadinov R, Bergsland N, Carl E, et al. Effect of Teriflunomide and Dimethyl Fumarate on Cortical Atrophy and Leptomeningeal Inflammation in Multiple Sclerosis: A Retrospective, Observational, Case-Control Pilot Study. J Clin Med. 2019;8(3)doi: 10.3390/jcm8030344.
Zivadinov, R., Bergsland, N., Carl, E., Ramasamy, D. P., Hagemeier, J., Dwyer, M. G., Lizarraga, A. A., Kolb, C., Hojnacki, D., & Weinstock-Guttman, B. (2019). Effect of Teriflunomide and Dimethyl Fumarate on Cortical Atrophy and Leptomeningeal Inflammation in Multiple Sclerosis: A Retrospective, Observational, Case-Control Pilot Study. Journal of clinical medicine, 8(3), . https://doi.org/10.3390/jcm8030344
Zivadinov, Robert, et al. "Effect of Teriflunomide and Dimethyl Fumarate on Cortical Atrophy and Leptomeningeal Inflammation in Multiple Sclerosis: A Retrospective, Observational, Case-Control Pilot Study." Journal of clinical medicine vol. 8,3 (2019). doi: https://doi.org/10.3390/jcm8030344
Zivadinov R, Bergsland N, Carl E, Ramasamy DP, Hagemeier J, Dwyer MG, Lizarraga AA, Kolb C, Hojnacki D, Weinstock-Guttman B. Effect of Teriflunomide and Dimethyl Fumarate on Cortical Atrophy and Leptomeningeal Inflammation in Multiple Sclerosis: A Retrospective, Observational, Case-Control Pilot Study. J Clin Med. 2019 Mar 12;8(3). doi: 10.3390/jcm8030344. PMID: 30870983; PMCID: PMC6463015.
Copy Download .nbib Format: NLM
Share it on

J Clin Med. 2019 Mar 12;8(3). doi: 10.3390/jcm8030344.

Effect of Teriflunomide and Dimethyl Fumarate on Cortical Atrophy and Leptomeningeal Inflammation in Multiple Sclerosis: A Retrospective, Observational, Case-Control Pilot Study.

Journal of clinical medicine

Robert Zivadinov, Niels Bergsland, Ellen Carl, Deepa P Ramasamy, Jesper Hagemeier, Michael G Dwyer, Alexis A Lizarraga, Channa Kolb, David Hojnacki, Bianca Weinstock-Guttman

Affiliations

  1. Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY 14203, USA. [email protected].
  2. Center for Biomedical Imaging at the Clinical Translational Science Institute, University at Buffalo, State University of New York, Buffalo, NY 14203, USA. [email protected].
  3. Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY 14203, USA. [email protected].
  4. Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY 14203, USA. [email protected].
  5. Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY 14203, USA. [email protected].
  6. Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY 14203, USA. [email protected].
  7. Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY 14203, USA. [email protected].
  8. Center for Biomedical Imaging at the Clinical Translational Science Institute, University at Buffalo, State University of New York, Buffalo, NY 14203, USA. [email protected].
  9. Jacobs Multiple Sclerosis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY 14203, USA. [email protected].
  10. Jacobs Multiple Sclerosis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY 14203, USA. [email protected].
  11. Jacobs Multiple Sclerosis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY 14203, USA. [email protected].
  12. Jacobs Multiple Sclerosis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY 14203, USA. [email protected].

PMID: 30870983 PMCID: PMC6463015 DOI: 10.3390/jcm8030344

[No abstract available.]

Keywords: brain atrophy; cortical atrophy; dimethyl fumarate; leptomeningeal enhancement; multiple sclerosis; teriflunomide

References

  1. Neuroimage. 2002 Sep;17(1):479-89 - PubMed
  2. Brain Pathol. 2004 Apr;14(2):164-74 - PubMed
  3. Brain. 2005 Nov;128(Pt 11):2705-12 - PubMed
  4. Neurology. 2008 Jul 8;71(2):136-44 - PubMed
  5. Ann Neurol. 2008 Sep;64(3):255-65 - PubMed
  6. Neuroimage. 2011 Jun 1;56(3):907-22 - PubMed
  7. Ann Neurol. 2011 Feb;69(2):292-302 - PubMed
  8. Neurology. 2011 Jul 19;77(3):257-63 - PubMed
  9. Hum Brain Mapp. 2012 Dec;33(12):2802-14 - PubMed
  10. N Engl J Med. 2011 Oct 6;365(14):1293-303 - PubMed
  11. Magn Reson Med. 2012 Sep;68(3):874-81 - PubMed
  12. N Engl J Med. 2012 Sep 20;367(12):1087-97 - PubMed
  13. N Engl J Med. 2012 Sep 20;367(12):1098-107 - PubMed
  14. Eur J Neurol. 2013 Jun;20(6):986-90 - PubMed
  15. Mult Scler. 2013 Aug;19(9):1175-81 - PubMed
  16. Hum Brain Mapp. 2014 Apr;35(4):1101-10 - PubMed
  17. AJNR Am J Neuroradiol. 2013 Oct;34(10):1931-9 - PubMed
  18. J Neurol Neurosurg Psychiatry. 2014 Aug;85(8):851-8 - PubMed
  19. Curr Neurol Neurosci Rep. 2013 Nov;13(11):394 - PubMed
  20. Neuroimage. 2014 Apr 15;90:207-17 - PubMed
  21. Lancet Neurol. 2014 Mar;13(3):247-56 - PubMed
  22. Exp Neurol. 2014 Dec;262 Pt A:57-65 - PubMed
  23. J Neurol. 2014 Sep;261(9):1794-802 - PubMed
  24. Lancet Neurol. 2014 Oct;13(10):977-86 - PubMed
  25. Mult Scler. 2015 May;21(6):749-56 - PubMed
  26. Neurology. 2015 Mar 17;84(11):1145-52 - PubMed
  27. Neurology. 2015 Jul 7;85(1):18-28 - PubMed
  28. Neurol Neuroimmunol Neuroinflamm. 2016 Jan 07;3(1):e190 - PubMed
  29. Mult Scler. 2016 Nov;22(13):1709-1718 - PubMed
  30. Expert Rev Neurother. 2016 Jul;16(7):777-93 - PubMed
  31. Mult Scler. 2017 May;23(6):818-829 - PubMed
  32. Mult Scler. 2017 Sep;23(10):1336-1345 - PubMed
  33. J Neurol. 2017 Mar;264(3):520-528 - PubMed
  34. J Neuroimaging. 2017 Sep;27(5):461-468 - PubMed
  35. Oncotarget. 2017 Jul 4;8(27):44266-44280 - PubMed
  36. PLoS One. 2017 Aug 10;12(8):e0182729 - PubMed
  37. Neurol Neuroimmunol Neuroinflamm. 2017 Aug 09;4(5):e390 - PubMed
  38. J Neurol Sci. 2017 Dec 15;383:221-229 - PubMed
  39. Front Neurol. 2017 Nov 10;8:577 - PubMed
  40. Neurobiol Aging. 2018 May;65:1-6 - PubMed
  41. AJNR Am J Neuroradiol. 2018 Apr;39(4):642-647 - PubMed
  42. Neurology. 2018 Apr 10;90(15):e1324-e1332 - PubMed
  43. J Neurol Sci. 2018 May 15;388:175-181 - PubMed
  44. Ther Adv Neurol Disord. 2018 Sep 10;11:1756286418796404 - PubMed
  45. J Neuroimaging. 2019 Jan;29(1):52-61 - PubMed
  46. Eur J Neurol. 2019 Mar;26(3):460-467 - PubMed
  47. J Neurol. 2018 Dec;265(12):2980-2992 - PubMed
  48. J Neurol. 2019 Feb;266(2):411-416 - PubMed
  49. J Neurol Neurosurg Psychiatry. 2019 Apr;90(4):458-468 - PubMed
  50. J Comp Eff Res. 2019 Apr;8(5):305-316 - PubMed

Publication Types

Grant support